A new case of ALG8 deficiency (CDG Ih)
- 18 August 2009
- journal article
- case report
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 32 (S1) , 259-264
Abstract
Congenital disorders of glycosylation (CDG) represent an expanding group of inherited diseases. One of them, ALG8 deficiency (CDG Ih), leads to protein N-glycosylation defects caused by malfunction of glucosyltransferase 2 (Dol-P-Glc:Glc1-Man9-GlcNAc2-P-P-Dol glucosyltransferase) resulting in inefficient addition of the second glucose residue onto lipid-linked oligosaccharides. So far, only five patients have been described with ALG8 deficiency. We present a new patient with neonatal onset. The girl was born at the 29th week of gestation complicated by oligohydramnios. Although the early postnatal adaptation was uneventful (Apgar score 8 and 9 at 5 and 10 min), generalized oedema, multifocal myoclonic seizures, and bleeding due to combined coagulopathy were present from the first day. Diarrhoea progressing to protein-losing enteropathy with ascites and pericardial effusion developed in the third week of life. Pharmacoresistant seizures and cortical, cerebellar and optic nerve atrophy indicated neurological involvement. No symptoms of liver disease except coagulopathy were observed; however, steatofibrosis with cholestasis was found at autopsy. The girl died at the age of 2 months owing to the progressive general oedema, bleeding and cardio-respiratory insufficiency. Molecular analysis revealed two heterozygous mutations in the ALG8 gene: c.139A>C (p.T47P) and the novel mutation c.1090C>T (p.R364X). Conclusion: The prognosis of patients with ALG8 deficiency is unfavourable. The majority of affected children have early onset of the disease with heterogeneous symptoms including multiple organ dysfunction, coagulopathy and protein-losing enteropathy. Neurological impairment is not a general clinical symptom, but it has to be taken into consideration when thinking about ALG8 deficiency.Keywords
This publication has 8 references indexed in Scilit:
- Human RFT1 Deficiency Leads to a Disorder of N-Linked GlycosylationThe American Journal of Human Genetics, 2008
- Congenital Disorders of Glycosylation: A Rapidly Expanding Disease FamilyAnnual Review of Genomics and Human Genetics, 2007
- Congenital disorder of glycosylation (CDG)-Ih patient with a severe hepato-intestinal phenotype and evolving central nervous system pathologyThe Journal of Pediatrics, 2005
- Clinical and molecular features of three patients with congenital disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency)Journal of Medical Genetics, 2004
- A Deficiency in Dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl α3-Glucosyltransferase Defines a New Subtype of Congenital Disorders of GlycosylationJournal of Biological Chemistry, 2003
- A case of the carbohydrate‐deficient glycoprotein syndrome type 1 (CDGS type 1) with normal phosphomannomutase activityJournal of Inherited Metabolic Disease, 1997
- Phosphomannomutase deficiency is a cause of carbohydrate‐deficient glycoprotein syndrome type IFEBS Letters, 1995
- The analysis of human serum transferrins with the PhastSystem: Quantitation of microheterogeneityElectrophoresis, 1992